Pharmacological or TRIB3-Mediated Suppression of ATF4 Transcriptional Activity Promotes Hepatoma Cell Resistance to Proteasome Inhibitor BortezomibTiit Örd, T. Örd|Cancers|2021Cited by 24
Genome-wide census of ATF4 binding sites and functional profiling of trait-associated genetic variants overlapping ATF4 binding motifsTiit Örd, T. Örd|PLoS Genetics|2023Cited by 13
Dissecting the polygenic basis of atherosclerosis using disease associated cell state signaturesTiit Örd, Minna U. Kaikkonen|Research Square|2022Cited by 0